CollabRx, Inc. Retains Hayden IR to Develop Strategic Investor Relations Program
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN FRANCISCO, July 25, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announced it has engaged Hayden IR, a 15-year-old, highly recognized, national investor relations firm, to raise the visibility of CollabRx and strengthen its relationships with the investment community
Help employers find you! Check out all the jobs and post your resume.
SAN FRANCISCO, July 25, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announced it has engaged Hayden IR, a 15-year-old, highly recognized, national investor relations firm, to raise the visibility of CollabRx and strengthen its relationships with the investment community
Help employers find you! Check out all the jobs and post your resume.